Asr Vermogensbeheer N.V. Bristol Myers Squibb CO Transaction History
Asr Vermogensbeheer N.V.
- $8.24 Trillion
- Q3 2025
A detailed history of Asr Vermogensbeheer N.V. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Asr Vermogensbeheer N.V. holds 234,416 shares of BMY stock, worth $10.9 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
234,416
Previous 235,404
0.42%
Holding current value
$10.9 Million
Previous $10.9 Billion
2.98%
% of portfolio
0.13%
Previous 0.14%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,665Shares Held
1.62BCall Options Held
22.4MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA196MShares$9.15 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.41 Billion0.15% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.42 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.02 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.31 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...